Clinical Trials Browser

Phase 1 × Matrix-M × Clear all

NCT04645147 2025-07-17

Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection

Phase 1 Active not recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections